ELISA detection of vivax malaria with recombinant multiple stage-specific antigens and its application to survey of residents in endemic areas.
10.3347/kjp.2003.41.4.203
- Author:
Sera KIM
;
Hye Jin AHN
;
Tong Soo KIM
;
Ho Woo NAM
- Publication Type:Original Article ; Evaluation Studies ; Research Support, Non-U.S. Gov't
- Keywords:
vivax malaria;
ELISA;
multiple antigens;
recombinant antigen;
serodiagnosis;
mass screening
- MeSH:
Animals;
Antibodies, Protozoan/*blood;
Antigens, Protozoan/genetics/*immunology;
*Endemic Diseases;
Enzyme-Linked Immunosorbent Assay/methods;
Humans;
Life Cycle Stages;
Malaria, Vivax/*diagnosis/epidemiology/parasitology;
Mass Screening;
Plasmodium vivax/*growth & development/immunology;
Recombinant Proteins/*immunology;
Serologic Tests
- From:The Korean Journal of Parasitology
2003;41(4):203-207
- CountryRepublic of Korea
- Language:English
-
Abstract:
An ELISA was developed for the diagnosis of vivax malaria using multiple stage-specific recombinant antigens of Plasmodium vivax. The DNA from the whole blood of a malaria patient was used as template to amplify the coding regions for the antigenic domains of circumsporozoite protein (CSP-1), merozoite surface protein (MSP-1), apical merozoite antigen (AMA-1), serine repeat antigen (SERA), and exported antigen (EXP-1). Each amplified DNA fragment was inserted into pQE30 plasmid to induce the expression of His-tagged protein in Escherichia coli (M15 strain) by IPTG. His-tagged proteins were purified by Ni-NTA metal-affinity chromatography and used as antigens for ELISA with patient sera that were confirmed previously by blood smear examinations. When applied to patient sera, 122 (80.3%) out of 152 vivax malaria cases reacted to at least one antigen, while no reactions were observed with 128 uninfected serum samples. We applied this ELISA to the screening of 3, 262 civilian residents in endemic regions near the DMZ, which resulted in 236 positively detected (7.2%) cases. This method can be applied to serological diagnosis and mass screening in endemic regions, or can be used as a safety test for transfusion blood in endemic areas.
